Kemanjuran Letrozole Dibandingkan dengan Clomiphene Citrate untuk Induksi Ovulasi pada Wanita dengan PCOS: Tinjauan Sistematis dan Analisis Meta
DOI:
https://doi.org/10.55606/klinik.v5i1.5552Keywords:
Clomiphene Citrate, Letrozole, Ovulation and Pregnancy, Polycystic Ovary Syndrome, Randomized Clinical TrialsAbstract
Polycystic ovary syndrome (PCOS) is the most common hormonal disorder in women of reproductive age and often causes ovulation disorders and infertility. For decades, clomiphene citrate (CC) was the go-to choice for stimulating ovulation, but letrozole is now considered a more effective alternative with the potential for better reproductive outcomes. This study systematically assessed the comparison of the effectiveness of letrozole and CC based on the PRISMA 2020 guidelines. Literature searches through PubMed and Google Scholar include randomized controlled clinical trials (RCTs) published between 2015–2025 in English, with a population of women diagnosed with PCOS. Data were combined using a fixed-effects model to calculate odds ratio (OR) and 95% confidence intervals, as well as assess heterogeneity through Cochran's Q and I² tests. Of the 11 RCTs involving 1,995 participants (1,000 using letrozole and 995 using CC), the rate of ovulation with letrozole ranged from 37.9–88%, while with CC it was 19.7–85.2%. Most studies showed significant improvements in ovulation and clinical pregnancy rates using letrozole (22–61%) compared to CC (13–43%). Overall, letrozole increased the chances of reproductive success (OR = 2.13; 95% CI = 1.73–2.61; p < 0.00001) with low heterogeneity, demonstrating better effectiveness and safety than CC.
References
Al-Shoraky, M. S., El-Din Hussien, H., & Ahmed El-Desouky, E. S. (2020). Letrozole versus clomiphene citrate for ovulation induction in women with polycystic ovary syndrome. Al-Azhar Medical Journal, 49(1), 209–218. https://doi.org/10.21608/amj.2020.67551
Al-Thuwaynee, S., & Swadi, A. A. J. (2023). Comparing efficacy and safety of stair step protocols for clomiphene citrate and letrozole in ovulation induction for women with polycystic ovary syndrome (PCOS): A randomized controlled clinical trial. Journal of Medicine and Life, 16(5), 725–730. https://doi.org/10.25122/jml-2023-0069
Amer, S. A., Smith, J., Mahran, A., Fox, P., & Fakis, A. (2017). Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Human Reproduction, 32(8). https://doi.org/10.1093/humrep/dex227
Badawy, A., & Elnashar, A. J. (2011). Treatment options for polycystic ovary syndrome. International Journal of Women's Health, 3, 25. https://doi.org/10.2147/IJWH.S11304
Bansal, S., Goyal, M., Sharma, C., & Shekhar, S. (2021). Letrozole versus clomiphene citrate for ovulation induction in anovulatory women with polycystic ovarian syndrome: A randomized controlled trial. International Journal of Gynecology & Obstetrics, 152(3), 345–350. https://doi.org/10.1002/ijgo.13375
Bulsara, J., Patel, P., Soni, A., & Acharya, S. (2021). A review: Brief insight into polycystic ovarian syndrome. Endocrine and Metabolic Science, 3, 100085. https://doi.org/10.1016/j.endmts.2021.100085
Casper, R. F., & Mitwally, M. F. (2011). Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome. Clinical Obstetrics and Gynecology, 54, 685–695. https://doi.org/10.1097/GRF.0b013e3182353d0f
Chakravorty, R., Athwal, A., Sur, D., & Saha, R. (2016). A prospective, randomized trial comparing the effects of letrozole versus clomiphene citrate for induction of ovulation and pregnancy rate in women with polycystic ovary syndrome. Fertility Science and Research, 3(2), 93–97. https://doi.org/10.4103/fsr.fsr_10_17
Dapas, M., & Dunaif, A. (2022). Deconstructing a syndrome: Genomic insights into PCOS causal mechanisms and classification. Endocrine Reviews, 43, 927–965. https://doi.org/10.1210/endrev/bnac001
De Leo, V., La Marca, A., & Petraglia, F. (2003). Insulin-lowering agents in the management of polycystic ovary syndrome. Endocrine Reviews, 24, 633–667. https://doi.org/10.1210/er.2002-0015
Dhurve, K., Narvekar, N., & Dhanvij, M. (2024). Study of the response of PCOS patients to clomiphene citrate based on hormonal parameters and body mass index. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 13(3), 624–629. https://doi.org/10.18203/2320-1770.ijrcog20240466
Ding, H., Zhang, J., Zhang, F., Zhang, S., Chen, X., Liang, W., & Xie, Q. (2021). Resistance to insulin and elevated level of androgen: A major cause of polycystic ovary syndrome. Frontiers in Endocrinology, 12, 741764. https://doi.org/10.3389/fendo.2021.741764
Ilangovan, S. (2024). A comparative study of letrozole and clomiphene citrate for ovulation induction in women with polycystic ovarian syndrome: A randomized controlled trial. https://doi.org/10.18203/2320-1770.ijrcog20241954
Kanbour, S. A., & Dobs, A. S. (2022). Hyperandrogenism in women with polycystic ovarian syndrome: Pathophysiology and controversies. Androgens: Clinical Research and Therapeutics, 3, 22–30. https://doi.org/10.1089/andro.2021.0020
Liu, C., Feng, G., Huang, W., Wang, Q., Yang, S., Tan, J., Fu, J., & Liu, D. (2017). Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: A prospective randomized trial. Gynecological Endocrinology, 33(11), 872–876. https://doi.org/10.1080/09513590.2017.1332174
Marshall, J. C., & Dunaif, A. (2012). Should all women with PCOS be treated for insulin resistance? Fertility and Sterility, 97, 18–22. https://doi.org/10.1016/j.fertnstert.2011.11.036
Mbi Feh, M. K., Patel, P., & Wadhwa, R. (2025). Clomiphene. In StatPearls [Internet] (Updated January 11, 2024). StatPearls Publishing.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction, 19, 41–47. https://doi.org/10.1093/humrep/deh098
Singh, S., Pal, N., Shubham, S., Sarma, D. K., Verma, V., Marotta, F., & Kumar, M. (2023). Polycystic ovary syndrome: Etiology, current management, and future therapeutics. Journal of Clinical Medicine, 12(4), 1454. https://doi.org/10.3390/jcm12041454
Takasaki, A., Tamura, I., Okada-Hayashi, M., Orita, T., Tanabe, M., Maruyama, S., Shimamura, K., & Morioka, H. (2018). Usefulness of intermittent clomiphene citrate treatment for women with polycystic ovarian syndrome that is resistant to standard clomiphene citrate treatment. Reproductive Medicine and Biology. https://doi.org/10.1002/rmb2.12219
Teede, H., Tay, C. T., Laven, J., et al. (2023). International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2023. The Australian NHMRC. https://doi.org/10.1016/j.fertnstert.2023.07.025
Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2008). Consensus on infertility treatment related to polycystic ovary syndrome. Human Reproduction, 23, 462–477. https://doi.org/10.1093/humrep/dem426
Walters, K. A., Gilchrist, R. B., Ledger, W. L., Teede, H. J., Handelsman, D. J., & Campbell, R. E. (2018). New perspectives on the pathogenesis of PCOS: Neuroendocrine origins. Trends in Endocrinology & Metabolism, 29, 841–852. https://doi.org/10.1016/j.tem.2018.08.005
Wang, L., Lv, S., Li, F., Bai, E., & Yang, X. (2021). Letrozole versus clomiphene citrate and natural cycle: Endometrial receptivity during implantation window in women with polycystic ovary syndrome. Frontiers in Endocrinology (Lausanne), 12, 676133. https://doi.org/10.3389/fendo.2020.532692
Wang, L., Wen, X., Lv, S., Zhao, J., Yang, T., & Yang, X. (2019). Comparison of endometrial receptivity of clomiphene citrate versus letrozole in women with polycystic ovary syndrome: A randomized controlled study. Gynecological Endocrinology, 35(10), 862–865. https://doi.org/10.1080/09513590.2019.1612358
Wasim, T., Nasrin, T., Zunair, J., & Irshad, S. (2024). Efficacy of letrozole vs clomiphene citrate for induction of ovulation in women with polycystic ovarian syndrome. Pakistan Journal of Medical Sciences, 40(1 Part-I), 78. https://doi.org/10.12669/pjms.40.1.7971
Witchel, S. F., Oberfield, S. E., & Peña, A. S. (2019). Polycystic ovary syndrome: Pathophysiology, presentation, and treatment with emphasis on adolescent girls. Journal of the Endocrine Society, 3, 1545–1573. https://doi.org/10.1210/js.2019-00078
Yang, A. M., Cui, N., Sun, Y. F., & Hao, G. M. (2021). Letrozole for female infertility. Frontiers in Endocrinology (Lausanne), 12, 676133. https://doi.org/10.3389/fendo.2021.676133
Zafar, T., Asif, F., Naurin, R., Majeed, T., & Mahmood, Z. (2021). Comparing effectiveness of letrozole versus clomiphene citrate to evaluate the ovulation induction in patients with polycystic ovarian syndrome. Age (Years), 26(4.81), 27–89.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jurnal Ilmiah Kedokteran dan Kesehatan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
